MNKD
MannKind Corporation · Healthcare · Biotechnology
Momentum inputs (comparable managers): holder breadth 0.0% · share flow -3.6% · net new positions 0.0% · formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 90 | 0 | 122.90M | $522.94M | +9 | −11 |
| Q1 2026 | 95 | -6 | 143.26M | $351.80M | +6 | −12 |
| Q4 2025 | 99 | +3 | 133.27M | $755.65M | +3 | n/a |
| Q3 2025 | 17 | -2 | 89.45M | $480.37M | +1 | −3 |
| Q2 2025 | 16 | 0 | 83.27M | $311.43M | n/a | n/a |
| Q1 2025 | 13 | 0 | 35.19M | $177.04M | n/a | n/a |
| Q4 2024 | 13 | 0 | 35.66M | $229.30M | n/a | n/a |
| Q3 2024 | 12 | +1 | 19.40M | $122.05M | +1 | n/a |
| Q2 2024 | 11 | n/a | 20.14M | $105.14M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passive) | 29.10M | n/a | $108.83M | 0.0% | n/c | 1 | SEC ↗ ×16 |
| 2 | The Vanguard Group ✦ (passive) | 18.16M | n/a | $67.92M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 3 | State Street Global Advisors ✦ (passive) | 10.75M | +13.5% | $40.19M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passive) | 7.62M | +12.2% | $28.49M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 5 | Millennium Management ✦ | 4.48M | -23.0% | $16.76M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 6 | Fidelity (FMR) ✦ | 3.95M | n/a | $14.78M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 7 | Two Sigma Investments ✦ | 2.53M | -24.8% | $9.45M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 8 | D. E. Shaw & Co. ✦ | 2.52M | -34.3% | $9.43M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 9 | Renaissance Technologies ✦ | 1.41M | -14.3% | $5.28M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 10 | Arrowstreet Capital ✦ | 1.10M | -59.5% | $4.11M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 11 | Wellington Management ✦ | 833.19K | +3.1% | $3.12M | 0.0% | ▲ Add | 5 | SEC ↗ ×5 |
| 12 | Marshall Wace ✦ | 275.04K | +201.2% | $1.03M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 13 | T. Rowe Price ✦ | 241.10K | +19.8% | $902,000 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 14 | Citadel Advisors ✦ | 185.49K | -44.0% | $693,748 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 15 | Gotham Asset Management ✦ | 71.19K | +6.7% | $266,247 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 45.67K | -17.5% | $170,810 | 0.0% | ▼ Trim | 5 | SEC ↗ ×3 |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 250 holders, 176.45M shares, $430.71M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Director · 39.05K sh · $128,478
Director · 33.56K sh · $127,856
Director · 39.05K sh · $158,547
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology